SHARE NOW
Phacilitate Unveils Full Agenda for Advanced Therapies Week 2025, Bringing Together Leaders to Shape the Future of Healthcare
Phacilitate is pleased to announce the release of the full agenda for Advanced Therapies Week 2025, set to take place from January 20-23 in Dallas, Texas.
Celebrating over two decades as the leading event in the advanced therapies space, this year’s gathering will once again serve as the premier destination for knowledge sharing, deal-making, and groundbreaking collaboration in cell and gene therapy biotech and pharmaceutical innovation.
Taking place in Dallas, Texas, a new biotech hub, we are excited to play host to 400 biotechs, large pharma, VCs, and cell and gene technology disruptors.
Attendees can expect an exceptional lineup of speakers, exclusive sessions, and networking opportunities designed to accelerate the industry’s ATMPs commercialization journey and foster advancements in life-changing treatments.
Agenda Highlights: An Unmatched Lineup of Expertise
The 2025 agenda has been curated to spark transformative discussions, ignite partnerships, and foster connections that will fuel industry progress and help advance the biotech industry toward delivering life-changing therapies to patients.
Attendees can look forward to insights from leading figures, including:
- Eytan Breman, Head of Research & Development, Celyad
- Nathan Moore, Head, Cell Therapy Technologies and Digital Transformation, Takeda
- Anthony Davies, Dark Horse Consulting Group
- Bo Wiinberg, Chief Business Officer, Cellerator
- Kasia Averall, Vice President of Quality, Quell Tx
The six-tracks agenda will cover key topics spanning regulatory pathways, clinical advancements, and innovative therapies, with featured events like the Women in Advanced Therapies Summit, Investment Summit, and the Superplenary – enabling you to showcase your pipeline progression in front of investors to secure funding and long-term partnerships.
An Event for Every Member of the Biotech Ecosystem
For over 20 years, Advanced Therapies Week has been the leading event for biotech and pharmaceutical professionals who are driving the next wave of breakthroughs in biopharma. Each year, the event serves as a catalyst for pioneering progress, blending deep industry insights with cutting-edge technology in an environment that thrives on collaboration.
“As we unveil the agenda for Advanced Therapies Week 2025, we’re reminded of the immense strides this community continues to make in delivering advanced therapies that improve lives,” said Kim Barnes, President of Phacilitate. “This event brings together the brightest minds and innovative companies, providing a unique platform for meaningful dialogue, collaboration, and inspiration. We’re excited to see the groundbreaking ideas and connections that will come from this year’s event.”
Register Now: Early Bird Prices End November 22nd
Phacilitate encourages potential attendees to take advantage of early bird prices, available through November 22nd. For more information and to view the full agenda, please visit advancedtherapiesweek.com or contact team@phacilitate.com.
About Phacilitate and Advanced Therapies Week
Phacilitate is dedicated to improving patient outcomes by supporting the development and delivery of life-changing treatments. By fostering collaboration among key players in advanced therapies, Phacilitate accelerates the commercialization journey for biotechs. Advanced Therapies Week is the flagship event, organized by Phacilitate, that brings this mission to life, bringing together thousands of leaders, innovators, and decision-makers each year to transform the future of healthcare.
Media Contact:
Michelle Boxall, CEO, IB Communications
